Nickel chloride administration prevents the growth of oral squamous cell carcinoma.

Nickel chloride administration prevents the growth of oral squamous cell carcinoma.
复制标题

DOI:
10.18632/oncotarget.25313
复制
发表时间:
2018-05-08
期刊:
影响因子:
--
通讯作者:
Asano M
Asano M
中科院分区:
其他
文献类型:
--
作者:
Ota H;Shionome T;Suguro H;Saito S;Ueki K;Arai Y;Asano M

文献摘要

相似文献

研究了NiCl 2对口腔鳞状细胞癌衍生细胞系HSC 3的影响。与1 mM NiCl 2孵育显着降低MMPs的表达在mRNA和蛋白质水平。将高转移亚细胞系HSC 3-M3接种于裸鼠舌面,建立裸鼠原位种植模型。注射1周后,用或不用含ImM NiCl 2的水喂养小鼠2至3周。免疫组织化学检查显示,MMP 9的表达显着减少NiCl 2喂养的小鼠。通过CT图像,在对照小鼠中观察到癌块为半透明区域。在喂食NiCl 2的小鼠中,在半透明区域内观察到许多高度半透明的区域。组织学上,该区域对应于肿瘤块中的坏死区域。实时荧光定量PCR分析显示,减少表达的血管生成因子,如IL-8和VEGF mRNA在NiCl 2喂养的小鼠。为了进一步研究NiCl 2对转移的影响,比较了区域淋巴结中的人β-珠蛋白基因表达。β-珠蛋白基因在NiCl 2喂养的小鼠中完全缺失。此外,通过PCR阵列分析,各种癌症转移相关基因在NiCl 2喂养的小鼠中被抑制。结果表明,NiCl 2可能是一种有前途的新型口腔癌治疗药物。
The effect of NiCl2 on oral squamous cell carcinoma-derived cell line HSC3 was examined. Incubation with 1 mM NiCl2 significantly reduced the expression of MMPs at mRNA and protein levels. The in vivo orthotopic implantation model was established by injecting highly metastatic subcell line HSC3-M3 to nude mouse tongue. After 1 week of injection, mice were fed with or without 1 mM NiCl2-containing water for two to three weeks. Immunohistochamical examination revealed that MMP9 expression was drastically reduced in NiCl2-fed mice. By CT images, cancer mass was observed as a translucent area in control mice. In NiCl2-fed mice, much highly translucent area was observed within the translucent area. Histologically, this area corresponded to the necrotic area in the tumor mass. Real-time PCR analysis revealed the reduced expression of angiogenic factors such as IL-8 and VEGF mRNA in NiCl2-fed mice. To further examine the effect of NiCl2 on metastasis, human β-globin gene expression in regional lymphnodes was compared. The β-globin gene was totaly absent in NiCl2-fed mice. Moreover, various cancer metastasis-related genes were inhibited in NiCl2-fed mice by PCR array analysis. The results indicated that NiCl2 might be a promising new anti-cancer therapeutics for the oral cancer treatment.